AC Immune SA reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was CHF 17.86 million compared to CHF 17.51 million a year ago. Basic loss per share from continuing operations was CHF 0.18 compared to CHF 0.21 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.77 USD | -2.05% | +2.58% | -4.60% |
May. 31 | BTIG Starts AC Immune With Buy Rating, $8 Price Target | MT |
May. 13 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.60% | 448M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- ACIU Stock
- News AC Immune SA
- AC Immune SA Reports Earnings Results for the First Quarter Ended March 31, 2024